What is Recursion Pharmaceuticals, Inc. Class A Common Stock's Enterprise Value?

Recursion Pharmaceuticals, Inc. Class A Common Stock's Enterprise Value is $1.4B, based on as-reported figures from SEC (XBRL) filings.

What is Recursion Pharmaceuticals, Inc. Class A Common Stock's Net Income (TTM)?

Recursion Pharmaceuticals, Inc. Class A Common Stock's Net Income (TTM) is -$518.9M, based on as-reported figures from SEC (XBRL) filings.

What is Recursion Pharmaceuticals, Inc. Class A Common Stock's Diluted EPS (TTM)?

Recursion Pharmaceuticals, Inc. Class A Common Stock's Diluted EPS (TTM) is -0.97, based on as-reported figures from SEC (XBRL) filings.

What is Recursion Pharmaceuticals, Inc. Class A Common Stock's EBITDA Margin?

Recursion Pharmaceuticals, Inc. Class A Common Stock's EBITDA Margin is -848.9%, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Recursion Pharmaceuticals, Inc. Class A Common Stock

XNAS · usd

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00PQ4XJ54

3.67▲ 0.09 (2.59%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 3.58
Day's Range: 3.49 – 3.68
52-Week Range: 2.77 – 6.50
Volume: 17.6M
Avg Volume: 28.4M

Share Statistics

Shares Outstanding
Employees: 600
Exchange: XNAS
Listed: 2021-04-16

Share count as of July 31, 2026

Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)

What is Recursion Pharmaceuticals, Inc. Class A Common Stock's Market Cap?: Recursion Pharmaceuticals, Inc. Class A Common Stock's Market Cap is $2.0B, based on as-reported figures from SEC (XBRL) filings.
What is Recursion Pharmaceuticals, Inc. Class A Common Stock's Enterprise Value?: Recursion Pharmaceuticals, Inc. Class A Common Stock's Enterprise Value is $1.4B, based on as-reported figures from SEC (XBRL) filings.
What is Recursion Pharmaceuticals, Inc. Class A Common Stock's Price / Sales?: Recursion Pharmaceuticals, Inc. Class A Common Stock's Price / Sales is 35.8×, based on as-reported figures from SEC (XBRL) filings.
What is Recursion Pharmaceuticals, Inc. Class A Common Stock's EV / Revenue?: Recursion Pharmaceuticals, Inc. Class A Common Stock's EV / Revenue is 26.2×, based on as-reported figures from SEC (XBRL) filings.
What is Recursion Pharmaceuticals, Inc. Class A Common Stock's EV / EBITDA?: Recursion Pharmaceuticals, Inc. Class A Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Recursion Pharmaceuticals, Inc. Class A Common Stock's Revenue (TTM)?: Recursion Pharmaceuticals, Inc. Class A Common Stock's Revenue (TTM) is $54.9M, based on as-reported figures from SEC (XBRL) filings.
What is Recursion Pharmaceuticals, Inc. Class A Common Stock's Net Income (TTM)?: Recursion Pharmaceuticals, Inc. Class A Common Stock's Net Income (TTM) is -$518.9M, based on as-reported figures from SEC (XBRL) filings.
What is Recursion Pharmaceuticals, Inc. Class A Common Stock's EBITDA?: Recursion Pharmaceuticals, Inc. Class A Common Stock's EBITDA is -$465.6M, based on as-reported figures from SEC (XBRL) filings.
What is Recursion Pharmaceuticals, Inc. Class A Common Stock's Diluted EPS (TTM)?: Recursion Pharmaceuticals, Inc. Class A Common Stock's Diluted EPS (TTM) is -0.97, based on as-reported figures from SEC (XBRL) filings.
What is Recursion Pharmaceuticals, Inc. Class A Common Stock's EBITDA Margin?: Recursion Pharmaceuticals, Inc. Class A Common Stock's EBITDA Margin is -848.9%, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · RXRXAs-filed SEC (XBRL) data